Doyle James Edward

Director at EXACT SCIENCES CORP

Sold, on record
$2.5M
Dollars the filings state
Form 4 sales
14
Latest Oct 9, 2025
Form 144 notices
6
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice EXACT SCIENCES CORPNotice
    Jul 27, 2023 2023

    Filed to sell 2,000 shares ($195k)

    Doyle James Edward, Director

    10b5-1 plan1x usual sizeFiling

  2. 2 Form 4 sale EXACT SCIENCES CORPRoutine
    Jul 27, 2023 same day

    Sold 2,000 shares at $97.42 ($195k)

    Doyle James Edward, Director

    10b5-1 planSold 3.7% of holdings ($5.3M position)52,110 shares left1x usual sizeFollows a Form 144Filing

  3. 3 Form 144 notice EXACT SCIENCES CORPNotice
    Mar 1, 2024 +218 days

    Filed to sell 2,000 shares ($115k)

    Doyle James Edward, Director

    10b5-1 plan1x usual sizeFiling

  4. 4 Form 4 sale EXACT SCIENCES CORPRoutine
    Mar 1, 2024 same day

    Sold 2,000 shares at $57.50 ($115k)

    Doyle James Edward, Director

    10b5-1 planSold 3.8% of holdings ($3M position)50,110 shares left1x usual sizeFollows a Form 144Filing

  5. 5 Form 144 notice EXACT SCIENCES CORPNotice
    Aug 13, 2025 +530 days

    Filed to sell 1,485 shares ($62k)

    Doyle James Edward, Director

    10b5-1 planFiling

  6. 6 Form 4 sale EXACT SCIENCES CORPRoutine
    Aug 13, 2025 same day

    Sold 1,485 shares at $42.02 ($62k)

    Doyle James Edward, Director

    10b5-1 planSold 2.4% of holdings ($2.6M position)59,962 shares leftFollows a Form 144Filing

  7. 7 Form 144 notice EXACT SCIENCES CORPNotice
    Oct 9, 2025 +57 days

    Filed to sell 2,000 shares ($120k)

    Doyle James Edward, Director

    10b5-1 planFiling

  8. 8 Form 4 sale EXACT SCIENCES CORPRoutine
    Oct 9, 2025 same day

    Sold 2,000 shares at $60.00 ($120k)

    Doyle James Edward, Director

    10b5-1 planSold 3.3% of holdings ($3.6M position)57,962 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (20)

Form 144 notices and Form 4 sales by Doyle James Edward
Source
Oct 9, 2025Oct 10, 2025EXACT SCIENCES CORPDirectorForm 4 sale2,000$120k3.3%RoutineSEC
Oct 9, 2025Oct 9, 2025EXACT SCIENCES CORPDirectorForm 144 notice2,000$120kNoticeSEC
Aug 13, 2025Aug 14, 2025EXACT SCIENCES CORPDirectorForm 4 sale1,485$62k2.4%RoutineSEC
Aug 13, 2025Aug 13, 2025EXACT SCIENCES CORPDirectorForm 144 notice1,485$62kNoticeSEC
Mar 1, 2024Mar 4, 2024EXACT SCIENCES CORPDirectorForm 4 sale2,000$115k3.8%RoutineSEC
Mar 1, 2024Mar 1, 2024EXACT SCIENCES CORPDirectorForm 144 notice2,000$115kNoticeSEC
Jul 27, 2023Jul 28, 2023EXACT SCIENCES CORPDirectorForm 4 sale2,000$195k3.7%RoutineSEC
Jul 27, 2023Jul 27, 2023EXACT SCIENCES CORPDirectorForm 144 notice2,000$195kNoticeSEC
Jun 9, 2023Jun 12, 2023EXACT SCIENCES CORPDirectorForm 4 sale1,402$127k2.5%RoutineSEC
Jun 9, 2023Jun 9, 2023EXACT SCIENCES CORPDirectorForm 144 notice1,402$127kNoticeSEC
May 26, 2023May 31, 2023EXACT SCIENCES CORPDirectorForm 4 sale2,000$161k3.7%RoutineSEC
May 26, 2023May 26, 2023EXACT SCIENCES CORPDirectorForm 144 notice2,000$161kNoticeSEC
Jul 30, 2021Aug 2, 2021EXACT SCIENCES CORPDirectorForm 4 sale2,640$293k8.1%Plan not statedSEC
Feb 26, 2021Mar 2, 2021EXACT SCIENCES CORPDirectorForm 4 sale2,000$260k6.2%Plan not statedSEC
Jul 31, 2020Aug 4, 2020EXACT SCIENCES CORPDirectorForm 4 sale2,539$239k7.3%Plan not statedSEC
Feb 28, 2020Mar 3, 2020EXACT SCIENCES CORPDirectorForm 4 sale2,000$155k5.8%Plan not statedSEC
Jul 31, 2019Aug 2, 2019EXACT SCIENCES CORPDirectorForm 4 sale2,808$331k7.5%Plan not statedSEC
Feb 28, 2019Mar 1, 2019EXACT SCIENCES CORPDirectorForm 4 sale2,000$192k5.4%Plan not statedSEC
Jul 30, 2018Aug 1, 2018EXACT SCIENCES CORPDirectorForm 4 sale1,318$78k3.4%Plan not statedSEC
Apr 10, 2018Apr 12, 2018EXACT SCIENCES CORPDirectorForm 4 sale3,098$127k8.1%Plan not statedSEC